Network pharmacology-based analysis of the mechanism of Saposhnikovia divaricata for the treatment of type I allergy
Li X, Li H, Wang T, Zhao Y, Shao Y, Sun Y, Zhang Y, Liu Z · Pharmaceutical Biology · 2022 June 27
DOI 10.1080/13880209.2022.2086583
Objective
Saposhnikovia divaricata (Turcz.) Schischk (Apiaceae) (SD) has various pharmacological activities, but its effects on type I allergy (TIA) have not been comprehensively studied. This study evaluates the treatment and molecular mechanisms of SD against TIA.
Conclusions
Saposhnikovia divaricata could inhibit mast cells, providing a scientific basis for further research and clinical applications of SD in TIA treatment.
Critical Appraisal
Published research can offer valuable insights, but a paper’s conclusions may go beyond what its results support. Critical appraisal examines the methods, findings and limitations to clarify what can reasonably be concluded—and what remains uncertain.
This article has not yet been critically appraised by the Research Hub.
Learn more about Critical Appraisal
